February 6, 2025 · Form 4 insider transaction
INGRAM DOUGLAS S bought 38,396 shares of Arrowhead Pharmaceuticals, Inc. at $20.09 per share, a transaction worth $771.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Represents shares underlying restricted stock units with a grant date 02/06/2025, which will vest in three years.